SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report
(Date of earliest event reported) January 12, 2018
(Exact name of registrant as specified in its charter)
|(State or other jurisdiction of||(Commission File Number)||(IRS Employer|
|156 Valleyview Road, Kelowna, BC Canada||V1X 3M4|
|(Address of principal executive offices)||(Zip Code)|
Registrants telephone number, including area code(250) 765-6412
(Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule
425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b -2 of this chapter).
Emerging growth company [ ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 3.02 Unregistered Sales of Equity Securities
On January 12, 2018, the Company announced it has closed the final tranche of CAD $80,550 for its Private Placement announced on October 26, 2017. Enertopia will be issuing 1,611,000 common shares at CAD$0.05 and 1,611,000 whole warrants that expire on January 12, 2020, with an exercise price of USD $0.06 during the 24 month period.
The Company reports one Director purchased 200,000 units of the above second tranche for proceeds of CAD $10,000 to the Company.
A cash finders fee for CAD $3,880 and 77,600 full broker warrants was paid to a third party. All full broker warrants expire on January 12, 2020 with the same exercise terms as noted above.
All issued shares will be subject to a hold period, for any resale into the United States under Rule 144, of six months and one day. Proceeds of the Private Placement will be used for continued Lithium Technology division development, project development and general working capital. The Private Placement will be subject to normal regulatory approvals.
The securities referred to herein will not be or have not been registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from registration requirements.
Item 7.01 Regulation FD Disclosure
A copy of the news release announcing the synthetic brine testing update for the recovery of Lithium is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.
A copy of the news release announcing it has closed the final tranche of CAD $80,550 for its Private Placement is filed as exhibit 99.2 to this current report and is hereby incorporated by reference.
Item 9.01 Financial Statements and Exhibits
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|/s/ Robert McAllister|
|Robert G. McAllister|
|CEO, President and Director|
|Date: January 12, 2018|